GRN and neoplasm: In these subgroup analyses, the negative prognostic value of GP88 staining on TCs was individually confirmed among patients with tumor stage 3+4, those with nodal stage N0, patients not treated with chemotherapy (CT−), as well as those with basal and especially luminal tumors in univariate analyses (Table 2 and Table 3).